A new study published in Cancer reveals that young women with breast cancer face persistent delays at multiple points in their care journey — and income plays a major role. Analyzing over 1,000 women aged 40 and under diagnosed between 2006 and 2016, researchers found that those earning less than $50,000 annually had nearly double the odds of waiting 90+ days before seeking care after noticing symptoms. Younger patients also faced greater barriers to timely diagnosis, with each additional year of age reducing diagnostic delay odds by 6%.

The study also surfaced a puzzling "survival paradox": treatment delays were paradoxically linked to longer disease-free survival in some analyses. Experts caution this reflects tumor biology — less aggressive cancers naturally allow more time before treatment and tend to have better outcomes — not evidence that delays are safe. Clinicians are urged not to dismiss breast cancer risk in younger patients, and the healthcare system must do more to remove financial barriers to timely care.

By the Numbers:

• 14% of patients experienced a presentation delay (≥90 days to seek care)
• 11% experienced a diagnostic delay (≥90 days from presentation to diagnosis)
• 22% experienced a treatment delay (≥60 days from diagnosis to treatment)
• Women earning <$50K had ~2x the odds of presentation delay (OR 1.98)
• Triple-negative breast cancer patients had significantly lower odds of all three delay types

Why it matters: With young-onset breast cancer on the rise, these findings highlight urgent gaps in healthcare access tied to income and age. Addressing socioeconomic disparities in health access and education may be instrumental in reducing delays — and ultimately saving lives.